Employees Retirement System of Texas’s Myriad Genetics MYGN Stock Holding History

Employees Retirement System of Texas’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-28,000	Closed	-$778K	–	1034
2019 Q2	$778K	Hold	28,000	–	–	0.01%	857
2019 Q1	$930K	Hold	28,000	–	–	0.01%	823
2018 Q4	$814K	Hold	28,000	–	–	0.01%	846
2018 Q3	$1.29M	Buy	+28,000	New	+$1.25M	0.02%	775

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Employees Retirement System of Texas's MYGN Position: Q3 2019 in Review

Employees Retirement System of Texas sold out of Myriad Genetics (MYGN) in Q3 2019, closing a stake of 28,000 shares — an estimated $778K sold.

Employees Retirement System of Texas first reported a position in MYGN in Q3 2018 and held it in 4 quarters. The position peaked at $1.29M in Q3 2018. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2019.

Employees Retirement System of Texas reported no remaining Myriad Genetics position as of Q3 2019 after selling out during the quarter.
Employees Retirement System of Texas sold 28,000 Myriad Genetics shares in Q3 2019, an estimated $778K.
Employees Retirement System of Texas first reported a position in Myriad Genetics in Q3 2018 and held it in 4 quarters.
Employees Retirement System of Texas's Myriad Genetics position peaked at $1.29M in Q3 2018.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2019.

Based on Employees Retirement System of Texas's 13F filing for Q3 2019, filed 12 Nov 2019.